Jean‐Pierre J. Issa

Generating author description...

All published works

Action	Title	Year	Authors
+ PDF Chat	Using short‐term response information to facilitate adaptive randomization for survival clinical trials	2009	Xuelin Huang Jing Ning Yisheng Li Elihu H. Estey Jean–Pierre J. Issa Donald A. Berry
+	A Parallel Phase I/II Clinical Trial Design for Combination Therapies	2006	Xuelin Huang Swati Biswas Yasuhiro Oki Jean–Pierre J. Issa Donald A. Berry

Common Coauthors

Coauthor	Papers Together
Xuelin Huang	2
Donald A. Berry	2
Jing Ning	1
Yisheng Li	1
Swati Biswas	1
Elihu H. Estey	1
Yasuhiro Oki	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+ PDF Chat	Bayesian Statistics and the Efficiency and Ethics of Clinical Trials	2004	Donald A. Berry	2
+ PDF Chat	Optimal two-stage designs for phase II clinical trials	1989	Richard Simon	2
+	Bayesian clinical trials	2006	Donald A. Berry	2
+	Adaptive assignment versus balanced randomization in clinical trials: A decision analysis	1995	Donald A. Berry Stephen G. Eick	2
+	Statistical Innovations in Cancer Research	2017	J. Jack Lee Donald A. Berry	2
+	The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent	1961	Edmund A. Gehan	1
+	Optimal adaptive randomized designs for clinical trials	2007	Cheng Yi Donald A. Berry	1
+	The Randomized Play-the-Winner Rule in Medical Trials	1978	L. J. Wei S. D. Durham	1
+	A Parallel Phase I/II Clinical Trial Design for Combination Therapies	2006	Xuelin Huang Swati Biswas Yasuhiro Oki Jean–Pierre J. Issa Donald A. Berry	1
+	Practical Bayesian Guidelines for Phase IIB Clinical Trials	1994	Peter F. Thall Richard H. Simon	1
+	Optimality, Variability, Power	2003	Feifang Hu William F. Rosenberger	1
+	A Bayesian group sequential design for a multiple arm randomized clinical trial	1995	Gary L. Rosner Donald A. Berry	1
+ PDF Chat	Response-Adaptive Randomization for Survival Trials: The Parametric Approach	2007	Lanju Zhang William F. Rosenberger	1
+	Play the Winner Rule and the Controlled Clinical Trial	1969	Marvin Zelen	1
+	Design and analysis of group sequential tests based on the type I error spending rate function	1987	KyungMann Kim David L. DeMets	1
+	Designs for Single‐ or Multiple‐Agent Phase I Trials	2004	Mark R. Conaway Stephanie Dunbar Shyamal D. Peddada	1
+ PDF Chat	Asymptotic Properties of Adaptive designs for Clinical Trials with delayed Response	2002	Zhidong Bai Feifang Hu William F. Rosenberger	1
+	Design and Analysis of Phase I Clinical Trials	1989	Barry E. Storer	1
+	A Multiple Testing Procedure for Clinical Trials	1979	Peter C. O’Brien Thomas R. Fleming	1
+ PDF Chat	Bayesian adaptive designs for clinical trials	2005	Cheng Yi Yu Shen	1
+	Dose‐Finding with Two Agents in Phase I Oncology Trials	2003	Peter F. Thall Randall E. Millikan Peter P. Mueller Sang Joon Lee	1
+	Continuous Bayesian adaptive randomization based on event times with covariates	2005	Ying Kuen Cheung Lurdes Y. T. Inoue J. Kyle Wathen Peter F. Thall	1
+	Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer	1990	John O’Quigley Margaret S. Pepe Lloyd D. Fisher	1
+	Two‐Dimensional Dose Finding in Discrete Dose Space	2005	Kai Wang Anastasia Ivanova	1
+	A Case Study of an Adaptive Clinical Trial in the Treatment of Out-Patients with Depressive Disorder	1994	Roy Tamura Douglas E. Faries John Sahl Andersen John H. Heiligenstein	1
+	Bayesian randomized clinical trials: A decision‐theoretic sequential design	2004	J. Andrés Christen Peter Müller Kyle Wathen Judith K. Wolf	1
+	Group sequential methods in the design and analysis of clinical trials	1977	Stuart J. Pocock	1
+	Seamlessly Expanding a Randomized Phase II Trial to Phase III	2002	Lurdes Y. T. Inoue Peter F. Thall Donald A. Berry	1
+ PDF Chat	Bayesian evaluation of group sequential clinical trial designs	2006	Scott S. Emerson John M. Kittelson Daniel L. Gillen	1
+	Bayesian Adaptive Biased‐Coin Designs for Clinical Trials with Normal Responses	2005	Anthony C. Atkinson Atanu Biswas	1
+	Selecting Drug Combinations Based on Total Equivalent Dose (Dose Intensity)	1990	Richard Simon Edward L. Korn	1
+	Bayesian two‐stage designs for phase II clinical trials	2002	Say‐Beng Tan David Machin	1
+	Selecting combinations of chemotherapeutic drugs to maximize dose intensity	1991	Richard Simon Edward L. Korn	1
+	The Phase II/III Transition	2000	Melissa Fazzari Glenn Heller Howard I. Scher	1
+	Using the tolerable-dose diagram in the design of phase I combination chemotherapy trials.	1993	Edward L. Korn Ronald Simon	1
+	Generalized Delayed Response in Randomized Play-the-Winner Rule	2003	Atanu Biswas	1
+	Optimal Adaptive Designs for Binary Response Trials	2001	William F. Rosenberger Nigel Stallard Anastasia Ivanova Cherice N. Harper Michelle L. Ricks	1